- Home
- MGX vs UPLD Comparison
MGX vs UPLD Comparison
Compare MGX & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- UPLD
- Stock Information
- Founded
- MGX 2018
- UPLD 2010
- Country
- MGX United States
- UPLD United States
- Employees
- MGX N/A
- UPLD N/A
- Industry
- MGX
- UPLD Computer Software: Prepackaged Software
- Sector
- MGX
- UPLD Technology
- Exchange
- MGX NYSE
- UPLD Nasdaq
- Market Cap
- MGX 62.1M
- UPLD 51.0M
- IPO Year
- MGX 2024
- UPLD 2014
- Fundamental
- Price
- MGX $2.17
- UPLD $1.93
- Analyst Decision
- MGX Strong Buy
- UPLD Hold
- Analyst Count
- MGX 4
- UPLD 1
- Target Price
- MGX $13.00
- UPLD N/A
- AVG Volume (30 Days)
- MGX 912.4K
- UPLD 101.3K
- Earning Date
- MGX 08-13-2025
- UPLD 07-31-2025
- Dividend Yield
- MGX N/A
- UPLD N/A
- EPS Growth
- MGX N/A
- UPLD N/A
- EPS
- MGX N/A
- UPLD N/A
- Revenue
- MGX $45,263,000.00
- UPLD $267,713,000.00
- Revenue This Year
- MGX N/A
- UPLD N/A
- Revenue Next Year
- MGX $11.75
- UPLD N/A
- P/E Ratio
- MGX N/A
- UPLD N/A
- Revenue Growth
- MGX N/A
- UPLD N/A
- 52 Week Low
- MGX $1.23
- UPLD $1.69
- 52 Week High
- MGX $5.50
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- MGX 71.83
- UPLD 48.12
- Support Level
- MGX $1.45
- UPLD $1.90
- Resistance Level
- MGX $2.47
- UPLD $2.08
- Average True Range (ATR)
- MGX 0.16
- UPLD 0.11
- MACD
- MGX 0.09
- UPLD 0.03
- Stochastic Oscillator
- MGX 75.47
- UPLD 59.21
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.